| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 1.59M | — |
| Operating expense | — | — |
| Net income | -3.40M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ATRA returned -21.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -46.4% |
| 1 year | -21.4% |
| 5 years | -97.4% |
| 10 years | -98.0% |
| All-time high | $1,403.50 (Jul 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ATRA would be worth today ›No. Atara Biotherapeutics, Inc. has not paid a dividend in the past 12 months.
Atara Biotherapeutics, Inc. stock trades on NASDAQ under the ticker symbol ATRA.
Atara Biotherapeutics, Inc. is part of the Healthcare sector.
Atara Biotherapeutics, Inc. has a market cap of 97.37M USD, based on the latest quote.
Atara Biotherapeutics, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
